Publications

Chappell GA, Heintz MM, Haws LC. 2021. Transcriptomic analyses of livers from mice exposed to 1,4-dioxane for up to 90 days to assess potential mode(s) of action underlying liver tumor development. Curr Res Toxicol 2:30–41; doi: 10.1016/j.crtox.2021.01.003. PMID: 34345848.

Miller B, Yao W, Dean R, Jensen IS, Cyr PL, Slocomb T. 2020. Abstract PMS57: Understanding the impact of XLMTM on parents and caregivers in the US: An analysis of survey results. Value in Health 23(Sup 2):S601; doi: 10.1016/j.jval.2020.08.1188.

Wikoff D, Lewis JR, Erraguntla N, Franzen A, Foreman J. 2020. Facilitation of risk assessment with evidence-based methods — A framework for use of systematic mapping and systematic reviews in determining hazard, developing toxicity values, and characterizing uncertainty. Regul Toxicol Pharmacol 118:104790; doi: 10.1016/j.yrtph.2020.104790. PMID: 33038430.

Purohit A, Jha R, Khalafallah AM, Price C, Rowan NR, Mukherjee D. 2020. Endoscopic endonasal versus transcranial approach to resection of olfactory groove meningiomas: A systematic review. Neurosurg Rev 43(6)1465-1471; doi: 10.1007/s10143-019-01193-2. PMID: 31709465.

Eichenbaum G, Yang K, Gebremichael Y, Howell BA, Murray FJ, Jacobson-Kram D, Jaeschke H, Kuffner E, Gelotte CK, Lai JCK, Wikoff D, Atillasoy E. 2020. Application of the DILIsym® Quantitative Systems Toxicology drug-induced liver injury model to evaluate the carcinogenic hazard potential of acetaminophen. Regul Toxicol Pharmacol 118(Dec):104788; doi: 10.1016/j.yrtph.2020.104788. PMID: 33153971.

VanderNoot N, Gerber NL. Defining sarcopenia and measuring the effects of muscle loss. George Mason University Celebration of Scholarship, Virtual, December 2020.

Cohen SS, Roger VL, Weston SA, Jiang R, Movva N, Yusuf AA, Chamberlain AM. 2020. Evaluation of claims-based computable phenotypes to identify heart failure patients with preserved ejection fraction. Pharmacol Res Persp 8(6):e00676; doi: 10.1002/prp2.676. PMID: 33124771.

Houben GF, Baumert JL, Blom WM, Kruizinga AG, Meima MY, Remington BC, Wheeler MW, Westerhout J, Taylor SL. 2020. Full range of population eliciting dose values for 14 priority allergenic foods and recommendations for use in risk characterization. Food Chem Toxicol 146(Dec)111831; doi: 10.1016/j.fct.2020.111831. PMID: 33166672.

Shoskes A, Migdady I, Rice C, Hassett C, Deshpande A, Price C, et al. 2020. Brain injury is more common in venoarterial extracorporeal membrane oxygenation than venovenous extracorporeal membrane oxygenation: A systematic review and meta-analysis. Crit Care Med 48(12):1799–1808; doi: 10.1097/CCM.0000000000004618. PMID: 33031150.

Li S, Liu J, Gong T, Guo H, Gawade PL, Kelsh MA, et al. 2020. Duration of short-acting granulocyte colony-stimulating factor for primary prophylaxis and risk of neutropenia-related hospitalization in older patients with cancer. J Geriatr Oncol 11(8):1309–1315; doi: 10.1016/j.jgo.2020.06.018. PMID: 32624415.

Ravandi F, Pierce S, Garcia-Manero G, Kadia T, Jabbour E, Borthakur G, … Kelsh M, et al. 2020. Salvage therapy outcomes in a historical cohort of patients with relapsed or refractory acute myeloid leukemia. Clin Lymphoma Myeloma Leuk 20(11):e871–e882; doi: 10.1016/j.clml.2020.06.007. PMID: 32792304.

Thompson CM, Gentry R, Fitch S, Lu K, Clewell HJ. 2020. An updated mode of action and human relevance framework evaluation for formaldehyde-related nasal tumors. Crit Rev Toxicol 50(10):919–952; doi: 10.1080/10408444.2020.1854679. PMID: 33599198.

Gentry R, Thompson CM, Franzen A, Salley J, Albertini R, Lu K, Greene T. 2020. Using mechanistic information to support evidence integration and synthesis: A case study with inhaled formaldehyde and leukemia. Crit Rev Toxicol 50(10):885–918; doi: 10.1080/10408444.2020.1854678. PMID: 33538218.

Nelms MD, Karmaus AL, Patlewicz G. 2020. An evaluation of the performance of selected (Q)SARs/expert systems for predicting acute oral toxicity. Comput Toxicol 16(Nov):100135; doi: 10.1016/j.comtox.2020.100135. PMID: 33163737.

Cekola P, Henrickson A, Cohen SS, Reichert H, Ararujo Torres K, Hulsey A. Growth and tolerance with an amino acid formula at a children’s center: A two-year retrospective review. Poster presented to North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), November 2020.

Karrar A, VanderNoot N, Kallman-Price J, Austin P, Escheik C, et al. Lower human activity profiles are associated with higher fatigue score in patients with non-alcoholic fatty liver disease (NAFLD) and hepatitis C virus (HCV). American Association for the Study of Liver Diseases Liver Meeting, Virtual, November 2020.

VanderNoot N, Short MI, Fongang B. Gut microbiome meta-analysis in Parkinson’s disease. Departmental talk, University of Texas Health Sciences Center, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Disease, Virtual, November 2020.

Gerber NL, Paik J, Younossi E, VanderNoot N, Golabi P, Younossi Z. 2020. Association between dietary factors and sarcopenia in patients with non-alcoholic fatty liver disease. Hepatology 72(S1):p1045A.

Karrar A, VanderNoot N, Kallman-Price J, Austin P, Escheik C, et al. 2020. Lower human activity profiles are associated with higher fatigue score in patients with non-alcoholic fatty liver disease (NAFLD) and hepatitis C virus (HCV). Hepatology 72(S1):p851.

Aerts M, Wheeler MW, Abrahantes JC. 2020. An extended and unified modeling framework for benchmark dose estimation for both continuous and binary data. Environmetrics 31(7):e2630; doi: 10.1002/env.2630. PMID: 36052215.